Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.98 - $115.74 $183 Million - $214 Million
1,851,500 Added 127.35%
3,305,400 $382 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $113 Million - $131 Million
1,168,000 Added 408.53%
1,453,900 $150 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $14.9 Million - $15.8 Million
139,200 Added 94.89%
285,900 $31.2 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $8.97 Million - $16.4 Million
143,800 Added 4958.62%
146,700 $16.7 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $35,352 - $50,802
600 Added 26.09%
2,900 $179,000
Q2 2022

Aug 08, 2022

SELL
$79.4 - $116.36 $8.11 Million - $11.9 Million
-102,100 Reduced 97.8%
2,300 $183,000
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $8.4 Million - $10.7 Million
97,200 Added 1350.0%
104,400 $11 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $384,384 - $467,649
3,900 Added 118.18%
7,200 $776,000
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $1.42 Million - $1.7 Million
-15,400 Reduced 82.35%
3,300 $361,000
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $707,168 - $786,544
8,200 Added 78.1%
18,700 $1.75 Million
Q1 2021

May 17, 2021

BUY
$71.83 - $95.48 $373,516 - $496,496
5,200 Added 98.11%
10,500 $966,000
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $1.86 Million - $2.34 Million
-27,700 Reduced 83.94%
5,300 $388,000
Q3 2020

Nov 16, 2020

SELL
$55.23 - $79.93 $867,111 - $1.25 Million
-15,700 Reduced 32.24%
33,000 $2.56 Million
Q2 2020

Aug 14, 2020

BUY
$30.2 - $56.98 $999,620 - $1.89 Million
33,100 Added 212.18%
48,700 $2.71 Million
Q1 2020

May 15, 2020

SELL
$24.87 - $38.56 $425,277 - $659,376
-17,100 Reduced 52.29%
15,600 $462,000
Q4 2019

Feb 14, 2020

SELL
$25.43 - $36.67 $33,059 - $47,671
-1,300 Reduced 3.82%
32,700 $1.18 Million
Q3 2019

Nov 14, 2019

BUY
$23.0 - $27.97 $66,700 - $81,113
2,900 Added 9.32%
34,000 $926,000
Q2 2019

Aug 14, 2019

BUY
$22.81 - $28.48 $709,391 - $885,728
31,100 New
31,100 $748,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.